Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Inactivated Rotavirus Vaccine
NCT06350058Phase 1Active, not recruiting
- Sponsor
- Zhifei Green Bamboo
- Start
- Aug 2021
- Primary completion
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Inactivated rotavirus vaccine in rotavirus infection (7 arms), sponsored by Zhifei Green Bamboo. Primary endpoints: Incidence rate of Adverse Events and Incidence rate of Serious Adverse Events up to 6 months. Started Aug 2021; status: active, not recruiting.
02
Drugs
Inactivated rotavirus vaccine
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT06350058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06350058.